Skip to main content

Table 5 Relapse rate classification. Comparison of the results of clinical, endoscopic and histopathological examinations conducted before treatment and after 6 months

From: The evaluation of three treatment protocols using oral prednisone and oral meloxicam for therapy of canine idiopathic lymphoplasmacytic rhinitis: a pilot study

 

Before treatment

6 months after treatment

Relapse rate%

Group

Dog

Clinical signs

Endoscopic changes

Histopathological changes

Clinical signs

Endoscopic changes

Histopathological changes

1

A

+++

+++

++

+

+

++

(12,5/25)

50

B

++

++

+

+

+

+

C

+

+

+

–

+

+

D

+

+

+

+/−

–

–

E

++

++

++

+

+

+

Total

25

12,5

2

A

+++

+++

+++

–

–

–

(0/29)

0

B

++

+

+

–

–

–

C

++

++

++

–

–

–

D

+

+

++

–

–

–

E

++

+

++

–

–

–

Total

29

0

3

A

+++

+++

+++

++

++

+++

(22/29)

75

B

++

++

++

+

+

++

C

++

++

++

+

+

++

D

+

+

++

+

+

+

E

+

++

+

+

+

++

Total

29

22

  1. - no changes (score of 0 points)
  2. +/− unremarkable
  3. + mild signs/changes (score of 1–3 points)
  4. ++ moderate signs/changes (score of 4–6 points)
  5. +++ severe signs/changes (score of 7–9 points)
  6. Group 1 - prednisone (Encorton)
  7. Group 2- meloxicam (Gromeloksin), followed by prednisone (Encorton)
  8. Group 3- meloxicam (Gromeloksin)
  9. Group 4- placebo (empty gelatin capsules)